The initial public offering (IPO) of Anthem Biosciences has seen strong investor interest, with the issue being subscribed 4.01 times…
Tag: Biosciences
Anthem Biosciences IPO: Is Anthem Biosciences IPO a risky bet for investors?
ET Intelligence Group: Anthem Biosciences, a contract research, development and manufacturing organisation (CRDMO), plans to raise ₹3,395 crore through an…
Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14
The initial public offering (IPO) of Anthem Biosciences will open for subscription on Monday, July 14. The Bengaluru-based CRDMO player…
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?
We recently published a list of 10 Small Cap Stocks with Huge Upside Potential. In this article, we are going…
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
Article content SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180),…
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…